Related references
Note: Only part of the references are listed.suPAR: A New Biomarker for Cardiovascular Disease?
Gethin W. Hodges et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Clinical Evaluation of Multiple Inflammation Biomarkers for Diagnosis and Prognosis for Patients with Systemic Inflammatory Response Syndrome
M. Reichsoellner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients
Katia Donadello et al.
JOURNAL OF CRITICAL CARE (2014)
Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome
R. B. Raggam et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Cigarette Smoking and Variations in Systemic Immune and Inflammation Markers
Meredith S. Shiels et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure
Alexander Koch et al.
LIVER INTERNATIONAL (2014)
Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
Eva Haastrup et al.
PLOS ONE (2014)
Soluble Urokinase Plasminogen Activator Receptor A Risk Factor for Carotid Plaque, Stroke, and Coronary Artery Disease
Margaretha Persson et al.
STROKE (2014)
Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
Stig Lyngbaek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
CRP and suPAR are differently related to anthropometry and subclinical organ damage
Stig Lyngbaek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
Thomas Huneck Haupt et al.
CRITICAL CARE (2012)
Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals
Anne Langkilde et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
suPAR - a future risk marker in bacteremia
Jesper Eugen-Olsen
JOURNAL OF INTERNAL MEDICINE (2011)
A catalogue of reporting guidelines for health research
I. Simera et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling
Francesco Blasi et al.
FEBS LETTERS (2010)
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
J. Eugen-Olsen et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism
Lars Tue Sorensen et al.
SURGERY (2010)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy
Ove Andersen et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Clinical significance of high-sensitivity C-reactive protein in cardiovascular disease
David Conen et al.
BIOMARKERS IN MEDICINE (2007)
C-Reactive protein and the prediction of cardiovascular events among those at intermediate risk - Moving an inflammatory hypothesis toward consensus
Paul M. Ridker
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology
Kristian Kofoed et al.
CLINICAL CHEMISTRY (2006)
Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo
N Sidenius et al.
FEBS LETTERS (2000)